04, 2025 (GLOBE NEWSWIRE) -- Noom, the leading digital healthcare company committed to chronic disease prevention and empowering people to live better longer, today announced the launch of the Noom Microdose GLP-1Rx Program, a groundbreaking offering designed to unlock weight loss and long-term health benefits while minimizing side effects through personalized microdoses of GLP-1 medication, when clinically appropriate
The clinic appears to use email mostly for automated order confirmations rather than two-way support
Well break down whats included in the program, how it compares to other GLP-1 options, and whether its the right fit for your health goals
Many patients report noticing improvements in energy, mood, and mental clarity within a few weeks, with physical changes developing over time with consistent treatment
Further research is clearly warranted to fully comprehend the interplay between gut microbiota, gut hormones, and cardiac function in HF